<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/Organization>
<http://www.news-medical.net/news/20130116/Reviva-Pharmaceuticals-completes-enrollment-in-RP5063-phase-2-trial-for-schizophrenia.aspx>